Avion Wealth’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4K Buy
17
+3
+21% +$789 ﹤0.01% 859
2026
Q1
$3K Hold
14
– – ﹤0.01% 792
2025
Q4
$3K Sell
14
-6
-30% -$1.59K ﹤0.01% 797
2025
Q3
$5K Buy
20
+8
+67% +$2.14K ﹤0.01% 649
2025
Q2
$3K Sell
12
-4
-25% -$974 ﹤0.01% 730
2025
Q1
$3K Hold
16
– – ﹤0.01% 649
2024
Q4
$3K Buy
16
+4
+33% +$918 ﹤0.01% 647
2024
Q3
$2K Buy
12
+2
+20% +$440 ﹤0.01% 697
2024
Q2
$2K Buy
10
+4
+67% +$814 ﹤0.01% 627
2024
Q1
$2K Hold
6
– – ﹤0.01% 708
2023
Q4
$1K Sell
6
-4
-40% -$840 ﹤0.01% 857
2023
Q3
$2K Buy
10
+3
+43% +$633 ﹤0.01% 493
2023
Q2
$1K Sell
7
-2
-22% -$388 ﹤0.01% 602
2023
Q1
$1K Buy
+9
New +$1.85K ﹤0.01% 455

Other funds holding LH

Avion Wealth's LH Position: Q2 2026 in Review

Avion Wealth increased its Labcorp (LH) stake by 21% in Q2 2026, buying an estimated $789 and bringing the position to 17 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #859.

Avion Wealth first reported a position in LH in Q1 2023 and has held it in 14 quarters since. The position peaked at $5K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Avion Wealth held 17 shares of Labcorp worth $4K as of Q2 2026.
  • Avion Wealth bought 3 Labcorp shares in Q2 2026, an estimated $789.
  • Labcorp made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #859 holding.
  • Avion Wealth first reported a position in Labcorp in Q1 2023 and has held it in 14 quarters since.
  • Avion Wealth's Labcorp position peaked at $5K in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.